Works about CASTRATION-resistant prostate cancer

Results: 2895
    1
    2
    3
    4
    5
    6
    7

    Treatment Patterns and Survival Among Veterans With De Novo Metastatic Hormone-Sensitive Prostate Cancer.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 5, p. e259433, doi. 10.1001/jamanetworkopen.2025.9433
    By:
    • Schoen, Martin W.;
    • Doherty, Jason;
    • Eaton, Daniel;
    • Khan, Saira;
    • Candelieri, Danielle;
    • Fedele, Nicholas;
    • Baxi, Priya;
    • Wynveen, Molly;
    • Pickett, Carley;
    • Wilson, R. Jackson;
    • Stackable, Kaitlin;
    • Ingram, Kara;
    • Karunanandaa, Krishny;
    • Agarwal, Rohan;
    • Rajasekhar, Abhinav;
    • Riekhof, Forest;
    • Govindan, Srinivas;
    • Cheranda, Nina;
    • Knoche, Eric M.;
    • Etzioni, Ruth D.
    Publication type:
    Article
    8

    A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer.

    Published in:
    BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04053-7
    By:
    • Lu, Xiaolin;
    • Dai, Tao;
    • Chen, Xue;
    • Wu, Bin;
    • Chen, Hui;
    • Wu, Jitao;
    • Yu, Dexin;
    • Ge, Huixin;
    • Li, Jian;
    • Huang, Houbao;
    • Fan, Tiwu;
    • Cheng, Linzhong;
    • Zhang, Xiaoping;
    • Zhang, Xuepei;
    • Yao, Xin;
    • Wei, Junli;
    • Xu, Zhenqiang;
    • Yang, Wenzeng;
    • He, Chaohong;
    • Luo, Jiexin
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials.

    Published in:
    World Journal of Urology, 2019, v. 37, n. 6, p. 1049, doi. 10.1007/s00345-018-2579-x
    By:
    • Ferro, Matteo;
    • Di Lorenzo, Giuseppe;
    • de Cobelli, Ottavio;
    • Bruzzese, Dario;
    • Pignataro, Piero;
    • Borghesi, Marco;
    • Musi, Gennaro;
    • Vartolomei, Mihai Dorin;
    • Cosimato, Vincenzo;
    • Serino, Alessandro;
    • Ieluzzi, Vincenzo;
    • Terracciano, Daniela;
    • Damiano, Rocco;
    • Cantiello, Francesco;
    • Mistretta, Francesco Alessandro;
    • Muto, Matteo;
    • Lucarelli, Giuseppe;
    • De Placido, Pietro;
    • Buonerba, Carlo
    Publication type:
    Article
    20
    21
    22
    23

    Are clinical guidelines designed according to guidelines? Cross-sectional assessment of quality and transparency of clinical guidelines in urology.

    Published in:
    World Journal of Urology, 2018, v. 36, n. 9, p. 1489, doi. 10.1007/s00345-018-2278-7
    By:
    • van den Bergh, Roderick C. N.;
    • Ost, Piet;
    • Surcel, Christian;
    • Valerio, Massimo;
    • Fütterer, Jurgen J.;
    • Gandaglia, Giorgio;
    • Sooriakumaran, Prasanna;
    • Tilki, Derya;
    • Tsaur, Igor;
    • Ploussard, Guillaume;
    • the European Association of Urology Working Party on Prostate Cancer (EAU-YAUWP)
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, p. 1, doi. 10.1038/s41698-024-00526-9
    By:
    • Walmsley, Charlotte S.;
    • Jonsson, Philip;
    • Cheng, Michael L.;
    • McBride, Sean;
    • Kaeser, Christopher;
    • Vargas, Herbert Alberto;
    • Laudone, Vincent;
    • Taylor, Barry S.;
    • Kappagantula, Rajya;
    • Baez, Priscilla;
    • Richards, Allison L.;
    • Noronha, Anne Marie;
    • Perera, Dilmi;
    • Berger, Michael;
    • Solit, David B.;
    • Iacobuzio-Donahue, Christine A.;
    • Scher, Howard I.;
    • Donoghue, Mark T. A.;
    • Abida, Wassim;
    • Schram, Alison M.
    Publication type:
    Article
    31
    32

    An appraisal of genetic testing for prostate cancer susceptibility.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00282-8
    By:
    • Finch, Amy;
    • Clark, Roderick;
    • Vesprini, Danny;
    • Lorentz, Justin;
    • Kim, Raymond H.;
    • Thain, Emily;
    • Fleshner, Neil;
    • Akbari, Mohammad R.;
    • Cybulski, Cezary;
    • Narod, Steven A.
    Publication type:
    Article
    33
    34

    Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response.

    Published in:
    JNCI Cancer Spectrum, 2023, v. 7, n. 6, p. 1, doi. 10.1093/jncics/pkad077
    By:
    • Parker, Chris;
    • Tunariu, Nina;
    • Tovey, Holly;
    • Alonzi, Roberto;
    • Blackledge, Matthew D;
    • Cook, Gary J R;
    • Chua, Sue;
    • Du, Yong;
    • Hafeez, Shaista;
    • Murray, Iain;
    • Padhani, Anwar R;
    • Staffurth, John;
    • Tree, Alison;
    • Stidwill, Helen;
    • Finch, Jessica;
    • Curcean, Andra;
    • Chatfield, Peter;
    • Perry, Sophie;
    • Koh, Dow-Mu;
    • Hall, Emma
    Publication type:
    Article
    35

    Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkaa003
    By:
    • Halabi, Susan;
    • Dutta, Sandipan;
    • Tangen, Catherine M;
    • Rosenthal, Mark;
    • Petrylak, Daniel P;
    • Thompson, Ian M;
    • Chi, Kim N;
    • Bono, Johann S De;
    • Araujo, John C;
    • Logothetis, Christopher;
    • Eisenberger, Mario A;
    • Quinn, David I;
    • Fizazi, Karim;
    • Morris, Michael J;
    • Higano, Celestia S;
    • Tannock, Ian F;
    • Small, Eric J;
    • Kelly, William Kevin
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    A prospective, multicenter study on the clinical effectiveness of abiraterone in metastatic castration-resistant prostate cancer in Korea: Pre- vs. post-chemotherapy.

    Published in:
    Investigative & Clinical Urology, 2023, v. 64, n. 5, p. 466, doi. 10.4111/icu.20230128
    By:
    • Seung-hwan Jeong;
    • Sang Eun Yeon;
    • Su Youn Kim;
    • Tae Gyun Kwon;
    • Seong Soo Jeon;
    • Young Deuk Choi;
    • Dongdeuk Kwon;
    • Byung Ha Chung;
    • Sung-Hoo Hong;
    • Byung Hoon Kim;
    • Hyo Jin Lee;
    • Sang Joon Shin;
    • Woo Suk Choi;
    • Sung Woo Park;
    • Taek Won Kang;
    • Seok Joong Yun;
    • Jin Seon Cho;
    • See Min Choi;
    • Na-Ri Lee;
    • Cheol Kwak
    Publication type:
    Article
    42
    43
    44
    45

    Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaïve patients with metastatic castration-resistant prostate cancer.

    Published in:
    Investigative & Clinical Urology, 2022, v. 63, n. 5, p. 546, doi. 10.4111/icu.20210450
    By:
    • Chung-Lin Lee;
    • Ying-Hsu Chang;
    • Chung-Yi Liu;
    • Ming-Li Hsieh;
    • Liang-Kang Huang;
    • Yuan-Cheng Chu;
    • Hung-Cheng Kan;
    • Po-Hung Lin;
    • Kai-Jie Yu;
    • Cheng-Keng Chuang;
    • Chun-Te Wu;
    • See-Tong Pang;
    • I-Hung Shao
    Publication type:
    Article
    46
    47
    48
    49
    50